Beyond lysis: how complement influences cell fate

被引:142
作者
Cole, DS [1 ]
Morgan, BP [1 ]
机构
[1] Univ Wales Coll Med, Dept Med Biochem & Immunol, Cardiff CF14 4XN, S Glam, Wales
关键词
apoptosis; C5a; cell death; complement; membrane attack complex; non-lethal effects;
D O I
10.1042/CS20020362
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Complement is a central component of the innate immune system involved in protection against pathogens. For many years, complement has been known to cause death of targets, either indirectly by attracting and activating phagocytes or directly by formation of a membrane pore, the membrane attack complex. More recently, it has been recognized that complement may cause other 'non-classical' effects that may not directly be aimed at killing of pathogens. Products of complement activation collaborate with the adaptive immune system to enhance responses to antigens. The membrane attack complex of complement, apart from lysing cells, can also trigger diverse events in target cells that include cell activation, proliferation, resistance to subsequent complement attack and either resistance to, or induction of, apoptosis. Various complement products play important roles in signalling for clearance by phagocytes of apoptotic self cells. Here we review some of these non-classical activities of complement and stress the roles that they may play in maintaining the integrity of the organism.
引用
收藏
页码:455 / 466
页数:12
相关论文
共 105 条
[1]   Molecular basis for a link between complement and the vascular complications of diabetes [J].
Acosta, J ;
Hettinga, J ;
Flückiger, R ;
Krumrei, N ;
Goldfine, A ;
Angarita, L ;
Halperin, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5450-5455
[2]  
[Anonymous], COMPLEMENT CLIN ASPE
[3]   The role of complement in inflammation and adaptive immunity [J].
Barrington, R ;
Zhang, M ;
Fischer, M ;
Carroll, MC .
IMMUNOLOGICAL REVIEWS, 2001, 180 :5-15
[4]   THE SPONTANEOUS APOPTOTIC CELL-DEATH OF NORMAL HUMAN-LYMPHOCYTES INVITRO - THE RELEASE OF, AND IMMUNOPROLIFERATIVE RESPONSE TO, NUCLEOSOMES INVITRO [J].
BELL, DA ;
MORRISON, B .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 60 (01) :13-26
[5]   TERMINAL COMPLEMENT PROTEINS C5B-9 RELEASE BASIC FIBROBLAST GROWTH-FACTOR AND PLATELET-DERIVED GROWTH-FACTOR FROM ENDOTHELIAL-CELLS [J].
BENZAQUEN, LR ;
NICHOLSONWELLER, A ;
HALPERIN, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :985-992
[6]   COMPLEMENT LYSIS - A HOLE IS A HOLE [J].
BHAKDI, S ;
TRANUMJENSEN, J .
IMMUNOLOGY TODAY, 1991, 12 (09) :318-320
[7]   FORMATION OF TRANSMURAL COMPLEMENT PORES IN SERUM-SENSITIVE ESCHERICHIA-COLI [J].
BHAKDI, S ;
KULLER, G ;
MUHLY, M ;
FROMM, S ;
SEIBERT, G ;
PARRISIUS, J .
INFECTION AND IMMUNITY, 1987, 55 (01) :206-210
[8]   Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity [J].
Bickerstaff, MCM ;
Botto, M ;
Hutchinson, WL ;
Herbert, J ;
Tennent, GA ;
Bybee, A ;
Mitchell, DA ;
Cook, HT ;
Butler, PJG ;
Walport, MJ ;
Pepys, MB .
NATURE MEDICINE, 1999, 5 (06) :694-697
[9]  
BORDET J, 1900, ANN I PASTEUR, V15, P257
[10]  
BORN J, 1986, IMMUNOLOGY, V59, P139